B12019 and Neulasta are formulations of pegfilgrastim, a pegylated form of the granulocyte colony-stimulating factor analog filgrastim, which mitigates the negative effects of chemotherapy on the ...

The FDA has approved Sandoz’s pegfilgrastim biosimilar ... market since last year and is a granulocyte colony stimulating factor (GCSF) class drug. Approval of Ziextenzo was based on a dossier ...